To take the analysis further, we take advantage of the RNA-seq data to divide these patients with AML into two groups (by deciles), showing high (90% decile) and low PRMT2 (10% decile) expression levels (PRMT2low, n = 37 and PRMT2high, n = 37; Table 1: patient characteristics), respectively. Here, PRMT2 is linked to acute myeloid leukemia.